GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Dividend-Payout-to-FFO

CTI BioPharma (FRA:CEPS) Dividend-Payout-to-FFO


View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


CTI BioPharma (FRA:CEPS) Business Description

Traded in Other Exchanges
N/A
Address
3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.